Roger Pomerantz

Roger Pomerantz has an estimated net worth of $20.6 Million. This is based on reported shares across multiple companies, which include Seres Therapeutics, Inc., Intec Pharma Ltd., Indaptus Therapeutics, Inc., CONTRAFECT Corp, Rubius Therapeutics, Inc., Viracta Therapeutics, Inc., and Enlivex Ltd..

2016 was Roger Pomerantz's most active year for acquiring shares with 20 total transactions. Roger Pomerantz's most active month to acquire stocks was the month of May. 2016 was Roger Pomerantz's most active year for disposing of shares, totalling 50 transactions. Roger Pomerantz's most active month to dispose stocks was the month of April. 2022 saw Roger Pomerantz paying a total of $1,665,000.00 for 687,418 shares, this is the most they've acquired in one year. In 2016 Roger Pomerantz cashed out on 1,360,965 shares for a total of $17,517,395.03, their largest year based on trade value.